Sort
82,697 grants matching “vaccine development”
Expanding the breadth, magnitude, and durability of PfSPZ vaccines by creating multi-strain vaccines, designer hybrid and genetically altered parasite vaccines and use of a unique adjuvant.
$1,083,506B. Kim Lee Sim · Sanaria, Inc. · U01 · FY2024 · AI
Genetic & structural basis for viral neutralization:Vaccinia and Influenza virus
$1,083,485James E Crowe · Vanderbilt University · N01 · FY2012 · AI
Development of Enabling Vector/Antigen Expression Technology for an Orally-Delive
$1,083,123B. Kim Lee Sim · Protein Potential, Llc · R01 · FY2015 · AI
Conserved Element DNA Vaccine
$1,083,056Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Prevention of AIDS
$1,083,056Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
DEVELOPMENT OF A NOVEL MULTIENVELOPE AIDS VACCINE
$1,082,912St. Jude Children'S Research Hospital · P01 · FY2000 · AI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Phase I Vaccine Trial for Influenza
$1,082,877Robert Frenck · Cincinnati Childrens Hosp Med Ctr · N01 · FY2019 · AI
TULANE NATINAL PRIMATE RESEARCH CENTER
$1,082,820Paul K Whelton · Tulane University Of Louisiana · P51 · FY2006 · RR
PRECLINICAL ASSAYS TO PREDICT TETRAVALENT DENGUE VACCINE EFFICACY
$1,082,808Aravinda M De Silva · Univ Of North Carolina Chapel Hill · R01 · FY2018 · AI
India International Center for Excellence in Research
$1,082,746Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
BABOON RESEARCH RESOURCE PROGRAM
$1,082,625Gary L White · University Of Oklahoma Hlth Sciences Ctr · P40 · FY2006 · RR
Multiscale Modeling of Influenza Neutralizing Antibody and Fc Effector Biology
$1,082,429Cliburn C Chan · Duke University · U01 · FY2025 · AI
Discovery of antiviral agents targeting dengue viral translation
$1,082,325Joseph Matthew Colacino · Ptc Therapeutics, Inc. · R56 · FY2012 · AI
National AIDS Research Institute (NARI), Pune, INDIA: Clinical Trials Unit
$1,082,288Arun R Risbud · National Aids Research Institute · UM1 · FY2014 · AI
Disease Modeling of Influenza and Other Emerging Respiratory Viral Pathogens
$1,082,258Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Center of Excellence on Race, Ethnicity and Health Disparities Research
$1,082,246Stephen B. Thomas · Univ Of Maryland, College Park · P20 · FY2016 · MD
Medical Scientist Training Program
$1,082,136Terence S. Dermody · Vanderbilt University · T32 · FY2011 · GM
Administrative Core
$1,081,575David Mitchell Smith · University Of California, San Diego · P30 · FY2021 · AI
Host and Viral Genetics Core
$1,081,268David B. Goldstein · Duke University · U19 · FY2009 · AI
Scientific Research Support Component C/Non- Human Primates
$1,081,255Dan H. Barouch · Scripps Research Institute, The · UM1 · FY2016 · AI
BABOON RESEARCH RESOURCE PROGRAM
$1,081,117Gary L White · University Of Oklahoma Hlth Sciences Ctr · P40 · FY2007 · RR
HIV-1 Reverse Transcriptase
$1,081,116Stephen H Hughes · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications
$1,081,004Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA
Using microfluidics to realize patient-specific anti-cancer immunotherapies
$1,080,800Polly Morrell Fordyce · Stanford University · DP1 · FY2024 · CA
Using microfluidics to realize patient-specific anti-cancer immunotherapies
$1,080,800Polly Morrell Fordyce · Stanford University · DP1 · FY2025 · CA